Clinical Utility of U‐p53AZ as a prognostic biomarker for the prediction of progression rate, in individuals with early stages of Alzheimer’s Disease

Background Despite recent success in AD clinical trials, many obstacles still prevent effectively halting disease progression. Many suspect that treating subjects earlier in the disease process will be key to providing more effective treatment. Better early diagnostics will aid the design and execut...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Alzheimer's & dementia 2024-12, Vol.20 (S8), p.n/a
Hauptverfasser:	Agus, Shmuel, Piccirella, Simona, Durrant, Abe, Duncan, Garrett B, Dickson, Samuel P., Hendrix, Suzanne B., Kinnon, Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!